GA Safety Promise Statement from Georgia Bio

Maria Thacker Goethe headshot

Dear Members and Partners,

The Center for Global Health Innovation and Georgia Bio advocate for science, communities, and global health. We believe science must be at the forefront of COVID-19 response and all worldwide health issues.

We believe in science, and we believe in communities. For the businesses who call these communities ‘home,’ science and public health recommendations are more important than ever in helping business owners and essential workers combat COVID-19.

For these reasons, we have signed the Georgia Safety Promise , a statewide public-private partnership that encourages businesses and communities to agree to simple, but critical, measures that will keep communities safe. Our collective knowledge of science shows us that the measures outlined in the Safety Promise are the best way to combat COVID-19 and its impact on our state.

The health and safety of our member companies’ employees is top of mind. We are concerned that any increase in COVID-19 cases in Georgia could impact the important work that the biopharmaceutical and MedTech companies are doing. Georgia companies and institutions have enhanced research and manufacturing capabilities for vaccines and treatments for COVID-19. Our member companies are committed to continuing the important work they do in Georgia, which is critical to our collective success to ultimately have a vaccine and treatment for COVID-19.

We encourage our partners and members to join us in supporting science by signing the Safety Promise. Wearing face coverings, washing your hands, sanitizing surfaces, and staying six feet apart are scientifically proven to reduce transmission of this virus.

I would like to also bring to your attention a new national public health campaign designed to mobilize support for vaccines. The Public Good Projects (PGP) in partnership with BIO launched a national public health campaign called STRONGER —a first-of-its-kind effort designed to combat the spread of vaccine misinformation online.

STRONGER provides a guide for individuals to combat misinformation, explaining how to spot it, and then block, hide, report, or respond to false posts with facts and a list of trusted experts as a resource for good information on vaccines on social media.

For more information, visit www.stronger.org and follow STRONGER on Facebook , Twitter , Instagram and YouTube. And don’t forget…follow us in signing the Safety Promise. Follow us in supporting the science.

Sincerely,
Maria Thacker-Goethe
President and CEO
Georgia Bio | Center for Global Health Innovation
Atlanta, Georgia

By Maria Thacker Goethe April 18, 2025
The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.
By Sheran Brown April 10, 2025
Georgia Life Sciences Selects Fulton County Schools Innovation Academy Student as the 2025 Georgia BioGENEius Winner Sandy Springs & Rockmart Teens Take Top Honors in Statewide Science Competition Atlanta, GA (April 4, 2025) – Georgia Life Sciences today named Bhavya Alapati , a junior at Fulton County Schools Innovation Academy, as the winner of the 2025 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. Eleven students from across Georgia competed for this year’s title and cash prize. Bhavya’s project investigated a novel method of identifying strokes using a device she created called SpectroStroke, a small-scale spectrophotometer, to detect homocysteine, an amino acid product that is associated with stroke. Bhavya identified the ability of homocysteine to be detected using Ellman’s reagent, which reacts with the free sulfhydryl group on the molecule to produce a yellow color. Bhavya created a wearable patch that contains the Ellman’s reagent. Then, she designed the SpectroStroke to be able to detect the color change when the patch is exposed to elevated levels of homocysteine. Bhavya’s SpectroStroke can detect normal levels of homocysteine up to extremely high levels seen in those experiencing a stroke. The ability to detect a stroke earlier would reduce damage and long-term effects of the condition. A future iteration of the SpectroStroke would include real-time monitoring capabilities to help track changing homocysteine levels. "Supporting and celebrating outstanding research and innovation in biotechnology is vital for the future of science and medicine. The Georgia BioGENEius Challenge not only encourages the brightest young minds to explore their potential but also nurtures the next generation of leaders who will drive groundbreaking advancements in biotechnology,” said Georgia Life Sciences President and CEO Maria Thacker-Goethe. “By recognizing and empowering these students, we are helping to shape a future where innovation thrives and the possibilities for improving lives are endless. Well done, Bhavya!” Georgia Life Sciences also congratulates the Georgia BioGENEius runner-up, Shelby Kendrick , who is a senior at Paulding County High School in Dallas, GA. Shelby’s research investigated the ability of Aspergillus terreus, a fungus found in soil, to degrade pre-treated polypropylene plastic (PP). This fungus has been discovered to produce high concentrations of degrading enzymes and raises the moisture level of its substrate. Shelby isolated the fungus from soil samples and confirmed the species using PCR amplification and DNA barcoding. Samples of polypropylene were pre-treated with 75% ethanol and UV exposure, then placed in a liquid culture of A. terreus in Minimal Salt Medium (MSM) media, and the culture was incubated for 23 days. At the end of the trial period, PP samples were analyzed using Scanning Electron Microscopy. These samples showed changes in their surface layer, indicating evidence of biodegradation. Polypropylene plastic is found in household items such as plastic cups and is a known problem in the environment due to its inability to degrade. Shelby’s future research on the use of A. terreus for biodegradation includes optimizing degradation conditions and assessing methods of application in the environment. Judging the 2025 Georgia BioGENEius Challenge were Ralph L. Cordell, CDC, and Alex Harvey, ViaMune. Cash prizes were awarded to Bhavya and Shelby. # # # About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
By Maria Thacker Goethe April 9, 2025
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition
MORE POSTS